RCM — R1 RCM Income Statement
0.000.00%
HealthcareAdventurousLarge Cap
- $6.04bn
 - $8.09bn
 - $2.25bn
 
Annual income statement for R1 RCM, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st  | 2020 December 31st  | R2021 December 31st  | 2022 December 31st  | 2023 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K/A | 10-K/A | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 1,186 | 1,271 | 1,475 | 1,806 | 2,254 | 
| Cost of Revenue | |||||
| Gross Profit | 198 | 250 | 314 | 360 | 485 | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,147 | 1,135 | 1,338 | 1,809 | 2,106 | 
| Operating Profit | 38.9 | 136 | 136 | -2.8 | 148 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.8 | 118 | 117 | -66.8 | 21 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 12 | 117 | 87.3 | -63.3 | 3.3 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | 12 | 117 | 87.3 | -63.3 | 3.3 | 
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.7 | 47.4 | -505 | -63.3 | 3.3 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.236 | 0.318 | -1.76 | 0.156 | 0.169 |